Home > News & Events > Current News > Introducing SATVI

Introducing SATVI

The South African Tuberculosis Vaccine Initiative (SATVI) is a University of Cape Town-based  Tuberculosis research group housed within the Institute of Infectious Diseases and Molecular Medicine,  accommodating several disciplines including paediatrics, infectious diseases, epidemiology, public health, immunology and clinical/biological sciences. SATVI has a large and well-developed clinical field site in the Boland Overberg region, with the core on the premises of the Brewelskloof TB Hospital in Worcester, from where most  clinical/epidemiological studies and clinical trials of new TB vaccines are conducted. 


The Immunology and Laboratory based work is led by Associate Professor Tom Scriba; and the Clinical Trials work is led by SATVI Director, Associate Professor Mark Hatherill, whilst the Operations are run by Dr Zameer Brey.